Foundation Medicine CEO sees no competition in cancer gene test market

Foundation Medicine, the maker of a genetic profiling test for cancer doctors and researchers, saw a big stock boost Wednesday after its quarterly earnings report showed a continued increase in the number of tests and revenue during the last three months of the year...